Efficacy and safety of adalimumab in the treatment of Crohn's disease in children

Objectives: to describe the efficacy and safety of adalimumab (ADA) in inducing clinical remission and reducing inflammation of intestinal mucosa in children with Crohn's disease (CD). Methods: we carried out a descriptive, observational study with all patients diagnosed with CD and treated wit...

Full description

Bibliographic Details
Main Authors: Víctor Manuel Navas-López, Javier Blasco-Alonso, Francisco Girón-Fernández-Crehuet, María Juliana Serrano-Nieto, Carlos Sierra-Salinas
Format: Article
Language:English
Published: Aran Ediciones 2013-12-01
Series:Revista Espanola de Enfermedades Digestivas
Subjects:
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082013001000002&lng=en&tlng=en